Clinical trials
Not yet recruiting Phase 1/2 Glioblastoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Advenchen Pharmaceuticals, LLC. | 1 |
| BreakBio Corp | 1 |
| First Affiliated Hospital of Wenzhou Medical University | 1 |
| Jubilant Therapeutics Inc. | 1 |
| Myosin Therapeutics Inc. | 1 |
| NeuGATE Theranostics | 1 |
| Sabine Mueller, MD, PhD | 1 |
| Shenzhen Geno-Immune Medical Institute | 1 |
| Starlight Therapeutics Inc. | 1 |
| University of Nebraska | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioblastoma | 10 |
| Glioma | 3 |
| Brain Neoplasms | 1 |
| Endometrial Neoplasms | 1 |
| Gliosarcoma | 1 |
| Meningeal Neoplasms | 1 |
| Ovarian Neoplasms | 1 |
| Recurrence | 1 |
| Sarcoma | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.